United in the fight against Covid-19. In a difficult time for Italy and the 
entire world, pharmaceutical company Menarini Group is taking healthcare 
professionals and patient health even more to heart.
  
The Board of Directors of Menarini, chaired by Eric Cornut, has decided to 
convert part of its production plant in Florence (Italy) to manufacturing 
disinfectant gel to be donated to those hospitals and healthcare organisations 
who are in the front line in the battle against Coronavirus.
  
Menarini will be producing 5 tons of disinfectant gel per week which will be 
distributed throughout the Italian territory and free of charge by Italy's 
national Civil Protection Department.
 
"Doctors and healthcare professionals are the true 'heroes' in the fight 
against COVID-19 and through our donation of disinfectant gel we hope to be 
able to help them work in greater safety", stated Elcin Barker Ergun, Chief 
Executive Officer Menarini Group.


The Menarini Group 
The Menarini Pharmaceutical Group, with headquarters in Florence, is present in 
more than 130 countries worldwide, with Euros 3,667 million in turnover and 
more than 17.000 employees. With 7 centres for Research & Development, Menarini 
products are present in the most important treatment areas, including 
cardiovascular, pulmonology, infectious diseases, diabetes, gastroenterology 
and anti-inflammatory/analgesic products. Pharmaceutical production is carried 
out in the Group's 16 manufacturing plants located in Italy and abroad, which 
produce and distribute over 585 million packets of product a year. Menarini's 
pharmaceutical production, in line with the highest quality standards, provides 
an ongoing contribution to the health of patients throughout the world.

Logo - https://mma.prnewswire.com/media/1134482/MENARINI_GROUP_Logo.jpg


Source: Menarini I.F.R.